COMPLETE BLOOD COUNT DEVICE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

A complete blood count (CBC), sometimes known as a full blood count (FBC), is a series of medical laboratory tests that give information regarding a person's blood cells. The CBC measures the number of white blood cells, red blood cells, and platelets, as well as hemoglobin concentration and hematocrit. The CBC is done with standard laboratory equipment or an automated hematological analyzer, which counts cells and records their size and structure. Three varieties of CBC devices exist: 3-part analyzer, 5-part analyzer, and 6-part analyzer.

The 3-part differential analyzer measures the volume of white blood cells electrically and classifies the cells based on their size, into three groups which include a small white blood cell group (lymphocytes), a medium-sized white blood cell group (monocytes, eosinophils, and basophils), and a large white blood cell group (neutrophils). A 5-part analyzer is a differential hematology instrument that uses the principle of flow cytometry to differentiate white blood cells (WBC) into their five major substitutes which include neutrophils, lymphocytes, monocytes, eosinophils, and basophils. 6-part analyzers are based on various technologies such as flow cytometry, light scattering, absorbance, electrical impedance, volume cytochemistry-based flow-cytometry, and other novel technologies.

Market Dynamics

Increasing approval of products launched by key players is expected to drive the growth of the global complete blood count device market in the forecast period. For instance, in January 2018, Abbott Laboratories announced that it had received CE Mark for its Alinity h-series integrated system for hematology testing. Moreover, the system offers high-throughput CBC analysis along with automated slide making and staining. It can perform 125 CBC per m2. It also integrates the Alinity hq with the Alinity hs slide maker and stainer module.

Key features of the study

• This report provides in-depth analysis of the global complete blood count device market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global complete blood count device market based on the following parameters – company highlights, types portfolio, key highlights, financial performance, and market strategies
• Key companies covered as a part of this study include Abbott Laboratories, bioMérieux SA, Danaher Corporation, Siemens Healthineers, Bio-Rad Laboratories, Inc., PerkinElmer, Inc., Sysmex Asia Pacific Pte Ltd, Becton, Dickinson and Company, Sight Diagnostics, Horiba, and Nihon Kohden Corporation
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global complete blood count device market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global complete blood count device market

Market Segmentation

• By Product type
  • 3-Part Analyzer
  • 5-Part Analyzer
  • 6-Part Analyzer
• By Modality
  • Portable
  • Stationary
• By Test Type
  • White Blood Cell Count (WBC or leukocyte count)
  • WBC Differential Count
  • Red Blood Cell Count (RBC or erythrocyte count)
  • Hematocrit (Hct)
  • Hemoglobin (Hbg)
  • Platelet Count
  • Mean Platelet Volume (MPV)
  • Mean Corpuscular Hemoglobin (MCH)
  • Others
• By End User
  • Hospitals
  • Diagnostic Laboratories
  • Research Institutes
  • Others
• By Region
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • Central Africa
    • North Africa
• Key Players
  • Abott Laboratories
  • bioMérieux SA
  • Danaher Corporation
  • Siemens Healthineers
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer, Inc.
  • Sysmex Asia Pacific Pte Ltd
  • Becton
  • Dickinson and Company
  • Sight Diagnostics
  • Horiba
  • Nihon Kohden Corporation